Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04404283 |
|---|---|
| Brief Title: | Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL |
| First Submitted : | May 21, 2020 |
| First Submitted that Met QC Criteria : | May 21, 2020 |
| First Posted : | May 27, 2020 |
| Last Update Submitted that Met QC Criteria : | February 28, 2021 |
| Last Update Posted : | March 2, 2021 |